Table 5 Details concerning applied RT dose and fractionating scheme for all patients of the study (N = 77) with corresponding EQD2 (α/β:10) and BED10
Applied Dose (Gy) | 1st Fractionation (Fractions*Gy) | 2nd Fractionation (Fractions*Gy) | 3rd Fractionation (Fractions*Gy) | EQD2 (α/β:10) | BED10 | Patients: N (%) | Primary Tumor | Bleeding stop achieved (%) | Comments |
|---|---|---|---|---|---|---|---|---|---|
9 | 3 × 3 |  |  | 9.75 | 11.7 | 4 (5.6) | H&N, pelvic A-CUP, CC, LC | 50 | 2/4 RT aborted due to death of patient |
10 | 1 × 10 |  |  | 16.67 | 20 | 1 (1.3) | OC | 100 | Brachytherapy |
10 | 2 × 5 |  |  | 12.5 | 15 | 1 (1.3) | BC | 100 | RT aborted prematurely after achieving bleeding stop due to general deterioration |
12 | 4 × 3 |  |  | 13 | 15.6 | 2 (2.6) | CC, EC | 100 |  |
12 | 6 × 2 |  |  | 12 | 14.4 | 1 (1.3) | CC | 100 | RT aborted prematurely after achieving bleeding stop due to patients’ decision |
13 | 3 × 3 | 2 × 2 |  | 13.75 | 16.5 | 1 (1.3) | pelvic A-CUP | 0 | RT aborted prematurely due to patients’ decision before achieving bleeding stop |
18 | 3 × 3 | 5 × 1.8 |  | 18.6 | 22.32 | 1 (1.3) | PC | 100 | RT aborted prematurely due to general deterioration |
19 | 3 × 3 | 5 × 2 |  | 19.75 | 23.7 | 1 (1.3) | EDC | 0 | 1/14 RT aborted prematurely without achieving bleeding stop due to patients ‘ decision |
20 | 5 × 4 |  |  | 23.33 | 28 | 1 (1.3) | RCC | 100 |  |
20 | 4 × 5 |  |  | 25 | 30 | 1 (1.3) | RC | 100 |  |
40 | 5 × 8 |  |  | 60 | 72 | 1 (1.3) | UC | 100 |  |
30 | 6 × 5 |  |  | 37.5 | 45 | 1 (1.3) | H&N | 100 | Brachytherapy |
24 | 1 × 3 | 1 × 5 | 1 × 4 | 27.17 | 32.6 | 1 (1.3) | EDC | 100 | 4th Fractionation: 4 × 3 Gy |
24 | 4 × 2 | 4 × 4 |  | 26.67 | 32 | 1 (1.3) | LC | 0 | RT aborted prematurely |
28.8 | 3 × 3 | 11 × 1.8 |  | 29.22 | 35.06 | 1 (1.3) | CC | 100 | RT aborted prematurely due to general deterioration |
30 | 15 × 2 |  |  | 30 | 36 | 3 (3.9) | MM: 2, CC | 100 | 1/3 low dose due to Reirraditation |
30 | 10 × 3 |  |  | 32.5 | 39 | 4 (5.2) | CC, BC, EC, PC | 50 | 4/4 RT aborted prematurely, 2/4 due to complications, 1/4 due to death by pulmonary artery embolism, 1/4 after achieving bleeding stop due to patients’ decision |
30.6 | 3 × 3 | 2 × 1.8 | 9 × 2 | 31.29 | 37.55 | 1 (1.3) | CC | 100 |  |
30.6 | 3 × 3 | 12 × 1.8 |  | 30.99 | 37.19 | 1 (1.3) | BLC | 100 |  |
33 | 11 × 3 |  |  | 35.75 | 42.9 | 1 (1.3) | LC | 0 | RT aborted due to death of patient |
36 | 13 × 2 |  |  | 36 | 43.2 | 1 (1.3) | BLC | 0 | RT aborted due to death of patient |
36 | 12 × 3 |  |  | 39 | 46.8 | 2 (2.6) | EDT | 100 | 1/2 RT aborted prematurely after achieving bleeding stop due to patients’ decision |
39 | 13 × 3 |  |  | 42.25 | 50.7 | 14 (18.2) | EDT: 3, LC: 3, UC: 3, BLC: 2, PC, H&N, RC | 85.7 |  |
40 | 20 × 2 |  |  | 40 | 48 | 4 (5.2) | GC, CC; BLC, PC | 100 |  |
45 | 15 × 3 |  |  | 48.75 | 58.5 | 2 (2.6) | BLC | 100 |  |
45 | 3 × 3 | 18 × 2 |  | 46.45 | 54.9 | 3 (3.9) | CC, EDT, US, UC | 100 |  |
45 | 1 × 3 | 21 × 2 |  | 45.25 | 54.3 | 1 (1.3) | EDT | 100 |  |
45 | 3 × 3 | 20 × 1.8 |  | 45.15 | 54.18 | 2 (2.6) | CC, OC | 100 |  |
45 | 25 × 1.8 |  |  | 44.25 | 53.1 | 4 (5.2) | CC, RC, AC, PaC | 100 |  |
49 | 3 × 3 | 20 × 2 |  | 49.75 | 59.7 | 2 (2.6) | CC, BLC | 100 |  |
50 | 25 × 2 |  |  | 50 | 60 | 1 (1.3) | LS, RC | 100 |  |
50.4 | 28 × 1.8 |  |  | 49.56 | 59.47 | 1 (1.3) | BLC | 100 | Change to curative concept after achieving bleeding stop |
54 | 3 × 3 | 25 × 1.8 |  | 54 | 64.8 | 1 (1.3) | RC | 100 | Change to curative concept after achieving bleeding stop |
59 | 3 × 3 | 25 × 2 |  | 59.75 | 71.7 | 1 (1.3) | LC | 100 | Change to curative concept after achieving bleeding stop |
59.4 | 33 × 1.8 |  |  | 58.41 | 70.09 | 1 (1.3) | CC | 100 |  |
59.4 | 3 × 3 | 28 × 1.8 |  | 59.31 | 71.17 | 7 (9) | CC | 100 | 5/7 Change to curative concept after achieving bleeding stop, additional Brachytherapy |
65 | 5 × 3 | 25 × 2 |  | 66.25 | 79.5 | 1 (1.3) | LC | 100 | Change to curative concept after achieving bleeding stop |